West Pharmaceutical Services WST Debt-to-equity

Debt-to-equity at other companies

Becton, Dickinson and CompanyBDX

0.6×-0.1×

AptarGroupATR

0.5×+0.1×

Halozyme TherapeuticsHALO

9.9×+6.7×

AVT

AvantorAVTR

0.7×0.0×

DowDOW

1.2×+0.1×

DuPont de Nemours, Inc.DD

0.2×-0.1×

FAQ

What is West Pharmaceutical Services's debt-to-equity?

West Pharmaceutical Services (WST) reported debt-to-equity of 0.1× in Q2 2026.

How has West Pharmaceutical Services's debt-to-equity changed year-over-year?

West Pharmaceutical Services's debt-to-equity increased by 0.6% year-over-year, from 0.1× to 0.1×.

What is the long-term trend for West Pharmaceutical Services's debt-to-equity?

Over 5 years (2020 to 2025), West Pharmaceutical Services's debt-to-equity has grown at a -10.2% compound annual growth rate (CAGR), from 0.2× to 0.1×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.